Changes in the prevalence of overweight, obesity, and severe obesity between 2010 and 2017 in preschoolers: A

Geoff D C Ball1, Anamaria Savu2, Padma Kaul2

  • 1Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Pediatric Obesity
|July 19, 2019
PubMed

Insights

Childhood obesity rates declined between 2010 and 2017 in Canadian preschoolers. However, severe obesity remained unchanged, indicating a need for targeted interventions to address this critical health issue.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a significant public health concern with long-term health implications.
  • Monitoring weight status trends in young children is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To evaluate trends in overweight, obesity, and severe obesity among 4- to 6-year-old children in Alberta, Canada, from 2010 to 2017.
  • To identify factors that may influence these weight status changes.

Main Methods:

  • Analysis of anthropometric data from 161,114 children aged 4-6 years collected during immunization visits.
  • Body Mass Index (BMI), BMI z scores, and weight status categories were determined using World Health Organization criteria.
  • Statistical analysis examined changes in prevalence over the 8-year study period, stratified by sex and considering socioeconomic factors.

Main Results:

  • A significant decrease in the prevalence of overweight (17.8% to 15.7%) and obesity (4.7% to 4.2%) was observed.
  • The prevalence of severe obesity remained stable (2.4% to 2.2%).
  • Overweight decreased in both boys and girls, while obesity decreased in boys but not significantly in girls. Severe obesity was stable in both sexes.

Conclusions:

  • While overall reductions in overweight and obesity are positive, the persistent high prevalence of severe obesity necessitates focused public health interventions.
  • Annual household income and breastfeeding showed positive but variable moderating effects on overweight and obesity.
  • Targeted strategies are essential to effectively reduce severe obesity rates in the preschool population.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.2K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
235
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
254
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
175
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.6K
What is Population Genetics?01:25

What is Population Genetics?

A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.5K